SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-135851
Filing Date
2016-11-22
Accepted
2016-11-22 13:11:34
Documents
1
Group Members
ALAIN L. AZANDR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLERIC P. BUATOISSOFINNOVA MANAGEMENT VI, L.L.C.SOFINNOVA VENTURE AFFILIATES VI, L.P.SOFINNOVA VENTURE PARTNERS VI GMBH & CO. KG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT 2 v453634_sc13da.htm SC 13D/A 165210
  Complete submission text file 0001144204-16-135851.txt   167048
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
SOFINNOVA VENTURE PARTNERS VI L P (Filed by) CIK: 0001211465 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88269 | Film No.: 162012514
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences